Recently I was dealing with a set of compounds with known target activities from the ChEMBL database, and I wanted to find out which of them also had PDB crystal structures in complex with that target.
Referencing this manually is very easy for cases where we are interested in 2-3 compounds, but for any larger number, using the ChEMBL and PDB web services greatly reduces the number of clicks.
Continue readingNow that PDBbind 2020 has been released, I want to draw some attention to an issue with using the SDF files that are supplied in the PDBbind refined set 2020.
Normally, SDF files save the chirality information of compounds in the atom block of the file which is shown belowas a snipped of the full sdf file for the ligand of PDB entry 4qsv. The column that defines chirality is marked in red.
As you can see, all columns shown here are 0. The SDF files supplied by PDBbind for some reason do NOT encode chirality information explicitly. This will be a problem when using RDKit to read the molecule and transform it into a smiles string. By using the following commands to read the ligand for 4qsv from PDBBind 2020 and write a SMILES string, we get:
Since its original publication in 2013, we have added several advanced search features to the Structural Antibody Database. This post aims to give an overview over some of these features.
Continue readingEarlier this month the World Health Organisation (WHO) released Proposed International Nonproprietary Name List 125 (PL125), comprising the therapeutics entering clinical trials during the first half of 2021. We have just added this data to our Therapeutic Structural Antibody Database (Thera-SAbDab), bringing the total number of therapeutic antibodies recognised by the WHO to 711.
This is up from 651 at the end of 2020, a year which saw 89 new therapeutic antibodies introduced to the clinic. This rise of 60 in just the first half of 2021 bodes well for a record-breaking year of therapeutics entering trials.
Continue readingBack in May 2020, we released the Coronavirus Antibody Database (‘CoV-AbDab’) to capture molecular information on existing coronavirus-binding antibodies, and to track what we anticipated would be a boon of data on antibodies able to bind SARS-CoV-2. At the time, we had found around 300 relevant antibody sequences and a handful of solved crystal structures, most of which were characterised shortly after the SARS-CoV epidemic of 2003. We had no idea just how many SARS-CoV-2 binding antibody sequences would come to be released into the public domain…
10 months later (2nd March 2021), we now have tracked 2,673 coronavirus-binding antibodies, ~95% with full Fv sequence information and ~5% with solved structures. These datapoints originate from 100s of independent studies reported in either the academic literature or patent filings.
After the stunning announcement at CASP14 that DeepMind’s AlphaFold 2 had successfully predicted the structures of proteins from their sequence alone, it’s hard to believe we began this journey by representing molecules with punched cards…
Tales of carrying stacks of punched cards to the computer centre with a line drawn diagonally on the side of the stack, to help put them back in order should you trip and fall—seem like another universe—but this is what passed for the human-computer interface in much of the mid-20th century.
Continue readingLast Wednesday, I was fortunate enough to be invited as a guest lecturer to the 3rd BioDataScience101 workshop, an initiative spearheaded by Paolo Marcatili, Professor of Bioinformatics at the Technical University of Denmark (DTU). This session, on amino acid sequence analysis applied to both proteomics and antibody drug discovery, was designed and organised by OPIG’s very own Tobias Olsen.
Continue readingA couple of weeks ago I was lucky enough to be asked to speak at the 5th Computational Drug Discovery & Development for Biologics Summit. This was my first virtual conference – it was a shame I didn’t get to visit Boston, and presenting to my empty room was slightly bizarre, but it was great to hear what people have been working on, and there’s definitely something to be said for attending a conference in fluffy socks…
.jpg){kind=link}